Abstract S108 Table 1

Findings stratified by NSBHR test result (data are presented as n(%) unless otherwise stated. P-values are calculated excluding the ‘not recorded’ data)

All
n=120
NSBHR+
(PC20 <8 mg/ml) n=19
NSBHR-
(PC20 ≥8 mg/ml) n=101
P-value
Male 105 (87.5)16 (84.2)89 (88.1)0.705
Age, median (range) 26 (23–31)29 (22–35)26 (23–31)0.375
Smoking
Current
Ever
Never
Not recorded
9 (7.5)
24 (20.0)
81 (67.5)
6 (5.0)
0 (0.0)
5 (26.3)
14 (73.7)
0 (0.0)
9 (8.9)
19 (18.8)
62 (66.3)
6 (5.9)
0.334
Atopic to common aeroallergens
Yes
No
Not recorded
87 (72.5)
19 (15.8)
14 (11.7)
18 (94.7)
0 (0.0)
1 (5.3)
69 (68.3)
19 (18.8)
13 (12.9)
0.038
Self-reported atopic disease
Yes
No
Not recorded
74 (61.7)
23 (19.2)
23 (19.2)
17 (89.5)
1 (5.3)
1 (5.3)
57 (56.4)
22 (21.8)
22 (21.8)
0.063
Adult symptoms/ treatment
Yes
No
Not recorded
84 (70.0)
34 (28.3)
2 (1.7)
15 (79.0)
4 (21.1)
0 (0)
69 (68.3)
30 (29.7)
2 (2.0)
0.590
Last treatment as an adult (any)
Never
> 1 year ago
<1 year ago
Not recorded
47 (39.2)
25 (20.8)
42 (35.0)
6 (5.0)
4 (21.1)
3 (15.8)
11 (57.9)
1 (5.3)
43 (42.6)
22 (21.8)
31 (30.7)
5 (5.0)
0.062
Childhood asthma (treatment and/or diagnosis) 100 (83.3)14 (73.7)86 (85.2)0.219
FEV1%predicted; mean (sd) 101.09 (12.5)93.1 (15.5)102.6 (11.3)0.002
FVC% predicted; mean (sd) 110.8 (12.0)106.6 (15.2)111.7 (11.2)0.090
FEV1/FVC, mean (sd) 0.78 (0.09)0.74 (0.06)0.79 (0.09)0.023